Oral and Maxillofacial Surgery, University Medical Centre of the Johannes Gutenberg University Mainz, Germany.
Oral Oncol. 2010 Feb;46(2):128-33. doi: 10.1016/j.oraloncology.2009.11.014. Epub 2010 Jan 8.
Glutathione S-transferases (GST) are antioxidant enzymes and oxidative stress markers in oral carcinogenesis. They present a system of polymorphic proteins. Some variants are associated with increased sensitivity to toxic compounds, as it is known for the GSTM1-null variant allele. However, the influence of the GSTM1 allele variant genotype on GSTM1-mRNA quantity in oral squamous cell carcinoma (OSCC) and normal mucosa as well as the impact on prognosis remains unclear. The genotype for GSTM1 (mutation vs. wild type) was determined by polymerase chain reaction (PCR) using genomic DNA extracted from peripheral blood from 28 OSCC patients. From the same patients, 28 pairs of OSCC cells and normal oral mucosal cells were obtained by brush biopsy. mRNA was extracted from these paired samples and the expression levels of GSTM1 were examined by real-time reverse transcriptase qPCR (RT-qPCR). The mRNA expression of the OSCC samples was normalized against an external standard, as well as to the corresponding normal mucosa. The coincidence of GSTM1 genotype and GSTM1-mRNA-expression level was examined. In 15 patients (54%), the null genotype GSTM1 was present. In the GSTM1-null allele group, the GSTM1 gene expression level was determined at 1.63 (mean: 3.08; SD 3.4) folds vs. 3.6 (mean: 10.5; SD 14.2) folds in the group with the positive genotype (p=0.06), if calibrated vs. individual normal mucosa. More T3 and T4 OSCCs (+38%), higher UICC stadia (+38%) and more lymphatic metastasis (+28%) were seen in the group with the negative allele. Furthermore, positive GSTM1 genotype and enhanced GSTM1 gene expression was accompanied with increased tumor size, lymphatic metastasis status and UICC stadium. A coincidence of null type GSTM1 and lowered GSTM1 gene expression was observed. The larger tumors and more frequent lymph node metastases in this group could be explained by the insufficient cell protection by GST.
谷胱甘肽 S-转移酶(GST)是口腔癌发生过程中的抗氧化酶和氧化应激标志物。它们表现出多态性蛋白质系统。一些变体与对有毒化合物的敏感性增加有关,正如 GSTM1 无效等位基因变体所知道的那样。然而,GSTM1 等位基因变体基因型对口腔鳞状细胞癌(OSCC)和正常黏膜中 GSTM1-mRNA 数量的影响以及对预后的影响尚不清楚。GSTM1(突变与野生型)的基因型通过聚合酶链反应(PCR)确定,使用从 28 例 OSCC 患者外周血中提取的基因组 DNA。从同一患者中,通过刷活检获得 28 对 OSCC 细胞和正常口腔黏膜细胞。从这些配对样本中提取 mRNA,并通过实时逆转录 qPCR(RT-qPCR)检查 GSTM1 的表达水平。OSCC 样本的 mRNA 表达与外部标准以及相应的正常黏膜进行归一化。检查 GSTM1 基因型和 GSTM1-mRNA 表达水平的一致性。在 15 名患者(54%)中,存在无效基因型 GSTM1。在 GSTM1 无效等位基因组中,GSTM1 基因表达水平被确定为 1.63(平均值:3.08;SD 3.4)倍,而在阳性基因型组中为 3.6(平均值:10.5;SD 14.2)倍(p=0.06),如果与个体正常黏膜相比。阴性等位基因组中观察到更多的 T3 和 T4 OSCC(+38%),更高的 UICC 分期(+38%)和更多的淋巴转移(+28%)。此外,阳性 GSTM1 基因型和增强的 GSTM1 基因表达伴随着肿瘤增大,淋巴转移状态和 UICC 分期的增加。观察到无效型 GSTM1 和降低的 GSTM1 基因表达之间的一致性。该组中较大的肿瘤和更频繁的淋巴结转移可以通过 GST 对细胞保护不足来解释。